BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 2878705)

  • 21. Prenatal diagnosis in a female carrying a deletion close to the Duchenne locus.
    Børresen AL; Boman H; Møller P; Berg K
    Prenat Diagn; 1988 Jan; 8(1):67-72. PubMed ID: 3422736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid carrier and prenatal diagnosis of Duchenne and Becker muscular dystrophy.
    Roberts RG; Cole CG; Hart KA; Bobrow M; Bentley DR
    Nucleic Acids Res; 1989 Jan; 17(2):811. PubMed ID: 2563578
    [No Abstract]   [Full Text] [Related]  

  • 23. Genetic counselling in Duchenne and Becker muscular dystrophy is problematic when carrier studies give controversial results.
    Kääriäinen H; Lindlöf M; Somer H; de la Chapelle A
    Clin Genet; 1990 Mar; 37(3):179-87. PubMed ID: 1969777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myotonic dystrophy: opportunities for prenatal prediction.
    Schrott HG; Omenn GS
    Neurology; 1975 Aug; 25(8):789-91. PubMed ID: 1171415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal deletion detection in a sporadic case of Duchenne muscular dystrophy without genotype information from the affected individual.
    Peinemann F; Wagner M; Franke U; Kulle M; Reiss J
    Eur J Pediatr; 1991 Feb; 150(4):256-8. PubMed ID: 1851486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic counselling for myotonic dystrophy: a comparison of lens examination and DNA linkage studies.
    Longstaff S; Curtis D; Quick J; Talbot J
    Eye (Lond); 1991; 5 ( Pt 1)():93-8. PubMed ID: 1676377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linkage analysis of polymorphisms within the DNA fragment XJ cloned from the breakpoint of an X;21 translocation associated with X linked muscular dystrophy.
    Thompson MW; Ray PN; Belfall B; Duff C; Logan C; Oss I; Worton RG
    J Med Genet; 1986 Dec; 23(6):548-55. PubMed ID: 2879926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of serum creatine kinase, pyruvate kinase, and genetic linkage for carrier detection in Duchenne and Becker dystrophy.
    Hyser CL; Griggs RC; Mendell JR; Polakowska R; Quirk S; Brooke MH; Fenichel GM; Doherty RA
    Neurology; 1987 Jan; 37(1):4-10. PubMed ID: 2879259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presymptomatic and prenatal diagnosis of myotonic muscular dystrophy with linked DNA probes.
    Milunsky JM; Skare JC; Milunsky A
    Am J Med Sci; 1991 Apr; 301(4):231-7. PubMed ID: 1672791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [DNA diagnosis of Duchenne muscular dystrophy].
    Matsumoto T
    No To Shinkei; 1991 May; 43(5):421-8. PubMed ID: 1680358
    [No Abstract]   [Full Text] [Related]  

  • 31. The value of deletion analysis for carrier detection in Duchenne muscular dystrophy (DMD).
    Bejjani B; Finn P; Milunsky A; Amos J
    Clin Genet; 1991 Apr; 39(4):245-52. PubMed ID: 2070545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal diagnosis of Duchenne muscular dystrophy: prospective linkage analysis and retrospective dystrophin cDNA analysis.
    Ward PA; Hejtmancik JF; Witkowski JA; Baumbach LL; Gunnell S; Speer J; Hawley P; Tantravahi U; Caskey CT
    Am J Hum Genet; 1989 Feb; 44(2):270-81. PubMed ID: 2643315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal diagnosis in Becker muscular dystrophy.
    Wood S; Shukin RJ; Yong SL; Wilson D; Kalousek D; Chudley A
    Clin Genet; 1987 Jan; 31(1):45-7. PubMed ID: 2882880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presymptomatic testing for myotonic dystrophy by means of the linked DNA marker APOC2.
    Haan EA; Mulley JC; Gedeon AK; Sheffield LJ; Sutherland GR
    Med J Aust; 1988 Sep; 149(6):326-9. PubMed ID: 3047535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal diagnosis using deletion studies in Duchenne muscular dystrophy.
    Speer MC; Pericak-Vance MA; Yamaoka LH; Koh J; Hung WY; Gaskell PC; Vance JM; Bartlett RJ; Roses AD
    Prenat Diagn; 1988 Jul; 8(6):427-37. PubMed ID: 3211845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of apolipoprotein CII as a genetic marker for myotonic dystrophy.
    Bird TD; Boehnke M; Schellenberg GD; Deeb SS; Lipe HP
    Arch Neurol; 1987 Mar; 44(3):273-5. PubMed ID: 2881531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic counseling of isolated carriers of Duchenne muscular dystrophy.
    Hoffman EP; Pegoraro E; Scacheri P; Burns RG; Taber JW; Weiss L; Spiro A; Blattner P
    Am J Med Genet; 1996 Jun; 63(4):573-80. PubMed ID: 8826437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of carriers of Duchenne muscular dystrophy: value of molecular analysis.
    LeRoy BS; Uhrhammer NA; Steere KJ; Boehm CD; King RA; Rich SS; Williams PP; Smith SA; de Martinville B
    Am J Med Genet; 1988 Nov; 31(3):709-21. PubMed ID: 2906525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dystrophin analysis in duchenne muscular dystrophy: use in fetal diagnosis and in genetic counseling.
    Bieber FR; Hoffman EP; Amos JA
    Am J Hum Genet; 1989 Sep; 45(3):362-7. PubMed ID: 2672800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal diagnosis of Duchenne muscular dystrophy by polymerase chain reaction analysis.
    Katayama S; Takeshita N; Yano T; Katagiri Y; Shirosita Y; Kubo H; Hirakawa S; Ubagai T
    Fetal Diagn Ther; 1994; 9(6):379-84. PubMed ID: 7880434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.